Advancing Pediatric Drug Development

Data requirement to facilitate Pediatric Drug Development

Briefly describe your research question :

How could we maximize use of all available data (e.g., existing clinical data in adults, in pediatric population in other diseases, MOA of drug, etiology of the disease, maturation of drug target, safety data in adults and pediatric patients on similar compounds, preclinical data, in vitro data etc.), to minimize data requirement from clinical trial in neonate and older pediatric population.




7 votes
Idea No. 118